Hospital discharge represents a critical window for diabetes intervention that most healthcare systems are missing. Despite continuous glucose monitoring becoming standard outpatient care, fewer than expected patients leave hospitals equipped with these devices that could prevent dangerous glucose swings and costly readmissions during the vulnerable transition home. Johns Hopkins has developed a systematic discharge protocol that tackles the practical roadblocks preventing wider CGM adoption at hospital exit. Their multidisciplinary approach addresses patient selection beyond traditional criteria, coordinates care teams across inpatient and outpatient settings, and provides structured education during a time when patients may have compromised cognitive function from illness or medications. The protocol emphasizes seamless handoffs to outpatient providers and ensures device compatibility with follow-up imaging studies. Early evidence suggests discharge-initiated CGM increases time-in-range metrics and reduces both hypoglycemic episodes and hospital readmissions compared to standard glucose monitoring approaches. However, this implementation framework arrives ahead of FDA approval for inpatient CGM use, creating a regulatory gap that hospitals must navigate carefully. The Hopkins model represents a pragmatic solution to therapeutic inertia and insurance barriers that have historically limited CGM access during discharge planning. While long-term cost-effectiveness data remains limited, the protocol provides actionable guidance for healthcare systems seeking to bridge the diabetes care gap between hospital and home environments, potentially transforming outcomes during this high-risk transition period.